We’re Speaking Out on Health Issues

NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.

Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.

Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.

NCHR joins Nonprofits in asking FDA to only allow Covid vaccine distribution after phase 3 trials completed

August 10, 2020. Experts urge that COVID-19 vaccines are made widely available only after the Food and Drug Administration (FDA) has been able to evaluate safety and efficacy data from completed Phase 3 clinical trials.

NCHR’s Public Comments on USPSTF’s Draft Recommendation Statement Regarding Lung Cancer Screening

Although we agree that the evidence suggests that the recommended changes in screening ages and pack-year history will lead to fewer lung cancer deaths, we have several suggestions for USPSTF to consider.

NCHR joins Nonprofits in criticizing White House blocking CDC from sharing Covid-19 data

July 23, 2020. Nonprofit coalition asks Sec. Azar to rescind guidance to stop reporting coronavirus data to CDC and send it only to HHS.

NCHR’s Public Comments on USPSTF’s Draft Research Plan Regarding Screening for Eating Disorders in Adolescents and Adults

We commend USPSTF’s intention to include studies that assess both the benefits and harms of the screening process for eating disorders. However, we have several suggestions.

NCHR Comments on USPSTF’s Draft Recommendation Regarding Screening for Hypertension in Adults

July 20, 2020. We support USPSTF’s reaffirmation of the 2015 recommendation statement on screening for high blood pressure in adults based on new scientific evidence and agree with USPSTF’s ‘A’ grade.